93 related articles for article (PubMed ID: 23564787)
1. Murine double minute 2 and its association with chemoradioresistance of esophageal squamous cell carcinoma.
Okamoto H; Fujishima F; Nakamura Y; Zuguchi M; Miyata G; Kamei T; Nakano T; Katsura K; Abe S; Taniyama Y; Teshima J; Watanabe M; Sato A; Ohuchi N; Sasano H
Anticancer Res; 2013 Apr; 33(4):1463-71. PubMed ID: 23564787
[TBL] [Abstract][Full Text] [Related]
2. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
[TBL] [Abstract][Full Text] [Related]
4. Significance of CD133 expression in esophageal squamous cell carcinoma.
Okamoto H; Fujishima F; Nakamura Y; Zuguchi M; Ozawa Y; Takahashi Y; Miyata G; Kamei T; Nakano T; Taniyama Y; Teshima J; Watanabe M; Sato A; Ohuchi N; Sasano H
World J Surg Oncol; 2013 Mar; 11():51. PubMed ID: 23448401
[TBL] [Abstract][Full Text] [Related]
5. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
6. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
8. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
9. Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatment.
Ikeguchi M; Ueda T; Fukuda K; Yamaguchi K; Tsujitani S; Kaibara N
Am J Clin Oncol; 2002 Oct; 25(5):454-9. PubMed ID: 12393983
[TBL] [Abstract][Full Text] [Related]
10. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
[TBL] [Abstract][Full Text] [Related]
14. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
[TBL] [Abstract][Full Text] [Related]
15. Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.
Nakanoko T; Saeki H; Morita M; Nakashima Y; Ando K; Oki E; Ohga T; Kakeji Y; Toh Y; Maehara Y
Ann Surg Oncol; 2014 Feb; 21(2):597-604. PubMed ID: 24065387
[TBL] [Abstract][Full Text] [Related]
16. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
17. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
18. Patient selection for salvage surgery after definitive chemoradiotherapy in esophageal squamous cell carcinoma.
Harada H; Yamashita K; Katada C; Ishiyama H; Soeno T; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Hiki N
Langenbecks Arch Surg; 2020 Sep; 405(6):767-776. PubMed ID: 32671456
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
[TBL] [Abstract][Full Text] [Related]
20. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
